Targeted therapies in HER2 positive breast cancer
Read time: 6 mins
Last updated:23th Aug 2019
Published:1st Aug 2019
This is the second of a four-part series looking at the latest trends in treatments developed for breast cancer. Here we highlight the current and latest therapies for the HER2 positive subtype of breast cancer, including trastuzumab and next generation treatments such as margetuximab.